Intimation of Change in designation of Directors by Shareholders approval.
Awaiting price reaction for this filing.
Gammon India's shareholders, at a meeting held on 5 December 2025, approved the formal appointment of four directors whose roles were previously held on an additional/interim basis. Mr. Vemparala Dakshinamurty (with the company since 1978) was confirmed as Whole-time Director designated as Executive Director for 3 years from 24 October 2025, while continuing as Chairman. Three Independent Directors — Mr. Ashok Bhutada (5-year term from 21 November 2025), Mr. Vishwas Joglekar (5-year term from 2 August 2025), and Dr. Lily Bhushan as Independent Women Director (5-year term from 25 March 2025) — were also confirmed for terms ending in 2030. All four directors are stated to be independent of the company's KMPs and not debarred by SEBI.
This is a routine governance housekeeping update confirming previously appointed directors, with no changes to control or strategy. Shareholders are unlikely to see a material stock price reaction since the board composition remains as already disclosed.